Raman Spectroscopy and Skin Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTiezhi Zhang
About this trial
The goal of this observational study is to find out if Raman Spectroscopy, a type of imaging, can be used to determine the size of skin cancer tumors. The main question it aims to answer is:
-Can Raman Spectroscopy help figure out how far a tumor spreads?
This study will take measurements using laser light from an experimental, handheld probe by lightly touching the skin.
Eligibility criteria
Qualifiers
Histologically confirmed skin cancer (either basal cell carcinoma or squamous cell carcinoma)
Participants must plan to receive brachytherapy treatment for the skin cancer at the study site.
Ability to provide consent to the study.
Disqualifiers
Patient belongs to a vulnerable population (Minors (under 18 years old), Adults unable to consent, prisoners).
Lesions on the eyelid or in close proximity to the eye
Pregnant women, or women of childbearing age who refuse pregnancy testing.
Patient has pacemaker.
Trial design
Treatments tested in this trial
- Raman Spectroscopy handheld probe (EmVision, FL, USA)
- Raman Spectroscopy laser source (Hubner Photonics Inc, CA, USA)
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Tiezhi Zhang
Lead sponsor
Stony Brook University
Sponsor institution
Source ClinicalTrials.gov